<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);
    }
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 24.2 - Secondary Amenorrhoea</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 24.2 - Secondary Amenorrhoea | MD3 SCP Cases">
  <meta name="description" content="A 27-year-old with 6 months of absent periods, weight loss, and galactorrhoea. Learn about causes of secondary amenorrhoea (pregnancy, PCOS, hyperprolactinaemia, hypothalamic), investigations (βhCG, prolactin, TFTs, FSH/LH), and management of hyperprolactinaemia.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://md3-scp.netlify.app/cases/case24_2.html">
  <meta property="og:title" content="Case 24.2 - Secondary Amenorrhoea">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="A 27-year-old with 6 months of absent periods, weight loss, and galactorrhoea. Learn about causes of secondary amenorrhoea (pregnancy, PCOS, hyperprolactinaemia, hypothalamic), investigations (βhCG, prolactin, TFTs, FSH/LH), and management of hyperprolactinaemia.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <!-- Twitter -->
  <meta property="twitter:card" content="summary">
  <meta property="twitter:title" content="Case 24.2 - Secondary Amenorrhoea">
  <meta property="twitter:description" content="A 27-year-old with 6 months of absent periods, weight loss, and galactorrhoea. Learn about causes of secondary amenorrhoea (pregnancy, PCOS, hyperprolactinaemia, hypothalamic), investigations (βhCG, prolactin, TFTs, FSH/LH), and management of hyperprolactinaemia.">
  <meta property="twitter:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">

  <link rel="stylesheet" href="../../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 24.2 – Secondary Amenorrhoea</h1>
    <p class="meta"><strong>Category:</strong> Medicine | <strong>Discipline:</strong> Obstetrics & Gynaecology | <strong>Setting:</strong> GP Surgery</p>

    <h2>Case</h2>
    <p>Miss Sophie Williams, a 27-year-old marketing executive, presents to her GP with a 6-month history of absent periods. Her last menstrual period was 6 months ago and was normal. Since menarche at age 13, her cycles have been regular (28-30 days) until they stopped 6 months ago.</p>

    <p>She denies being sexually active and has not been in a relationship for over a year. She has noticed occasional milky nipple discharge (galactorrhoea) over the past 3 months, which appears spontaneously without manipulation. She also reports frequent headaches (frontal, worse in mornings) and has noticed her peripheral vision seems slightly reduced when driving.</p>

    <p>Sophie has lost approximately 8kg over the past year (BMI reduced from 24 to 21). She attributes this to increased stress at work and reduced appetite. She exercises regularly (gym 4-5 times per week, running 10km twice weekly). She denies hot flushes, mood changes, or symptoms of virilisation (acne, hirsutism, deepening voice).</p>

    <p>Past medical history is unremarkable. She takes no regular medications and denies use of recreational drugs. She is a non-smoker and drinks alcohol socially. There is no family history of endocrine disorders.</p>

    <div class="vital-signs">
      <strong>On Examination:</strong>
      <ul>
        <li>General: Appears well, BMI 21</li>
        <li>Vital signs: BP 118/72 mmHg, HR 64 bpm, Temperature 36.7°C</li>
        <li>Breasts: Milky discharge expressible from both nipples (galactorrhoea), no masses</li>
        <li>Abdominal examination: Soft, non-tender, no masses</li>
        <li>No hirsutism, acne, or signs of virilisation</li>
        <li>Visual field testing: Possible bitemporal hemianopia (difficult to assess in clinic)</li>
      </ul>
    </div>

    <h2>Investigations</h2>
    <div class="investigation-results">
      <strong>Bedside:</strong>
      <ul>
        <li>Urine βhCG: Negative</li>
      </ul>
      <strong>Bloods:</strong>
      <ul>
        <li><strong>Prolactin:</strong> 4200 mU/L (normal &lt;500 mU/L in women) - Markedly elevated</li>
        <li>TSH: 2.8 mU/L (normal 0.4-4.0)</li>
        <li>Free T4: 14 pmol/L (normal 10-20)</li>
        <li>FSH: 3.2 IU/L (normal follicular phase 3-10)</li>
        <li>LH: 2.8 IU/L (normal follicular phase 2-10)</li>
        <li>Testosterone: 1.2 nmol/L (normal &lt;2.5 in women)</li>
        <li>Oestradiol: Low</li>
      </ul>
      <strong>MRI Pituitary (Urgent):</strong>
      <ul>
        <li><strong>12mm pituitary macroadenoma</strong> (prolactinoma)</li>
        <li>Extension into suprasellar space with compression of optic chiasm</li>
        <li>No cavernous sinus invasion</li>
      </ul>
    </div>

    <h2>Questions</h2>

        <div class="question">
      <strong>Question 1: What are the causes of secondary amenorrhoea, and how should it be investigated?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Definition:</strong> Secondary amenorrhoea = absence of menstruation for >3 months in a woman with previously regular cycles, OR >6 months in woman with previously irregular cycles.</p>

        <p><strong>Causes of Secondary Amenorrhoea (4-tier classification):</strong></p>

        <p><strong>1. Hypothalamic causes (35%):</strong></p>
        <ul>
          <li><strong>Functional hypothalamic amenorrhoea:</strong>
            <ul>
              <li><strong>Stress</strong> - psychological, illness</li>
              <li><strong>Weight loss/low BMI (\&lt;18.5)</strong> - anorexia nervosa, excessive exercise</li>
              <li><strong>Excessive exercise</strong> - athletes, gymnasts (female athlete triad: amenorrhoea + osteoporosis + eating disorder)</li>
            </ul>
          </li>
          <li>Mechanism: ↓ GnRH pulsatility → ↓ FSH/LH → ↓ oestrogen → amenorrhoea</li>
          <li>Bloods: Low FSH, Low LH, Low oestradiol</li>
        </ul>

        <p><strong>2. Pituitary causes (20%):</strong></p>
        <ul>
          <li><strong>Hyperprolactinaemia (prolactinoma or other causes):</strong>
            <ul>
              <li>Prolactin inhibits GnRH → ↓ FSH/LH → amenorrhoea + galactorrhoea</li>
              <li>Causes: Prolactinoma (pituitary adenoma), medications (antipsychotics, metoclopramide, domperidone), hypothyroidism</li>
              <li>Bloods: High prolactin (\&gt;1000 suggests prolactinoma), low FSH/LH</li>
            </ul>
          </li>
          <li><strong>Sheehan syndrome:</strong> Postpartum pituitary necrosis (following massive PPH)</li>
          <li><strong>Other pituitary tumours:</strong> Non-functioning adenomas, craniopharyngioma</li>
        </ul>

        <p><strong>3. Ovarian causes (40%):</strong></p>
        <ul>
          <li><strong>Polycystic ovary syndrome (PCOS):</strong> Most common cause overall
            <ul>
              <li>Hyperandrogenism (acne, hirsutism), insulin resistance, polycystic ovaries on USS</li>
              <li>Bloods: High LH:FSH ratio (\&gt;2:1), high testosterone, high insulin</li>
            </ul>
          </li>
          <li><strong>Premature ovarian insufficiency (POI):</strong> Menopause &lt;40 years
            <ul>
              <li>Symptoms: Hot flushes, night sweats, vaginal dryness</li>
              <li>Bloods: High FSH (\&gt;25 IU/L on 2 occasions), low oestradiol</li>
              <li>Causes: Idiopathic, autoimmune, Turner syndrome (45,XO), chemotherapy/radiotherapy</li>
            </ul>
          </li>
        </ul>

        <p><strong>4. Uterine/outflow tract causes (5%):</strong></p>
        <ul>
          <li><strong>Asherman syndrome:</strong> Intrauterine adhesions (synechiae)
            <ul>
              <li>Following D&C, endometritis, surgery</li>
              <li>Diagnosis: Hysteroscopy (gold standard)</li>
            </ul>
          </li>
          <li><strong>Cervical stenosis:</strong> Following LLETZ, cone biopsy, cervical surgery</li>
        </ul>

        <p><strong>Always exclude FIRST:</strong></p>
        <ul>
          <li><strong>PREGNANCY</strong> - most common cause! Always do urine βhCG first</li>
        </ul>

        <p><strong>Investigations for Secondary Amenorrhoea:</strong></p>

        <p><strong>First-line (all patients):</strong></p>
        <ul>
          <li><strong>Urine βhCG</strong> - Exclude pregnancy (mandatory!)</li>
          <li><strong>Serum prolactin</strong> - Hyperprolactinaemia (prolactinoma, medications, hypothyroidism)</li>
          <li><strong>TFTs (TSH, free T4)</strong> - Hypothyroidism (can cause ↑ prolactin and amenorrhoea)</li>
          <li><strong>FSH and LH</strong> - Determine level of dysfunction:
            <ul>
              <li>Low FSH/LH → hypothalamic/pituitary cause</li>
              <li>High FSH → ovarian failure (POI)</li>
              <li>High LH:FSH ratio (\&gt;2:1) → PCOS</li>
            </ul>
          </li>
          <li><strong>Testosterone</strong> - Hyperandrogenism (PCOS, androgen-secreting tumour if very high)</li>
        </ul>

        <p><strong>Second-line (guided by first-line results):</strong></p>
        <ul>
          <li><strong>Pelvic ultrasound:</strong> Assess ovaries (polycystic morphology), uterus, endometrial thickness</li>
          <li><strong>MRI pituitary:</strong> If prolactin >1000 mU/L or visual field defects/headaches</li>
          <li><strong>Karyotype:</strong> If POI suspected (especially if &lt;30 years) - exclude Turner syndrome</li>
          <li><strong>Hysteroscopy:</strong> If Asherman syndrome suspected (history of D&C/endometritis)</li>
        </ul>

        <p><strong>This patient's investigations reveal:</strong></p>
        <ul>
          <li>Negative βhCG → pregnancy excluded</li>
          <li><strong>Very high prolactin (4200 mU/L)</strong> → hyperprolactinaemia</li>
          <li>Normal TFTs → hypothyroidism excluded</li>
          <li>Low FSH/LH → pituitary/hypothalamic cause (as expected with high prolactin)</li>
          <li><strong>MRI: 12mm prolactinoma</strong> (pituitary macroadenoma)</li>
          <li>Galactorrhoea + headaches + visual field defect consistent with prolactinoma with mass effect</li>
        </ul>
      </div>
    </div>

        <div class="question">
      <strong>Question 2: What is hyperprolactinaemia, and how is it managed?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Hyperprolactinaemia:</strong> Elevated serum prolactin >500 mU/L (normal &lt;500 in women, &lt;450 in men).</p>

        <p><strong>Causes of Hyperprolactinaemia:</strong></p>
        <ul>
          <li><strong>Physiological:</strong> Pregnancy, breastfeeding, stress, exercise, sexual intercourse</li>
          <li><strong>Prolactinoma (pituitary adenoma secreting prolactin):</strong>
            <ul>
              <li><strong>Microadenoma:</strong> &lt;10mm (prolactin usually 1000-5000 mU/L)</li>
              <li><strong>Macroadenoma:</strong> >10mm (prolactin usually >5000 mU/L)</li>
              <li>More common in women (microprolactinomas), men present later with macroprolactinomas</li>
            </ul>
          </li>
          <li><strong>Medications:</strong> Antipsychotics (risperidone, haloperidol), metoclopramide, domperidone, SSRIs, verapamil</li>
          <li><strong>Hypothyroidism:</strong> ↑ TRH → ↑ prolactin</li>
          <li><strong>Pituitary stalk compression:</strong> Non-functioning pituitary tumours (↓ dopamine delivery → ↑ prolactin)</li>
          <li><strong>Chronic renal failure:</strong> Reduced prolactin clearance</li>
          <li><strong>PCOS:</strong> Mild elevation (500-1000)</li>
        </ul>

        <p><strong>Clinical Features of Hyperprolactinaemia:</strong></p>
        <ul>
          <li><strong>Women:</strong>
            <ul>
              <li>Oligomenorrhoea/amenorrhoea (prolactin inhibits GnRH)</li>
              <li>Galactorrhoea (40-80% of cases)</li>
              <li>Infertility</li>
              <li>Reduced libido</li>
              <li>Vaginal dryness (due to low oestrogen)</li>
            </ul>
          </li>
          <li><strong>Men:</strong>
            <ul>
              <li>Erectile dysfunction</li>
              <li>Reduced libido</li>
              <li>Infertility</li>
              <li>Galactorrhoea (rare)</li>
              <li>Gynaecomastia</li>
            </ul>
          </li>
          <li><strong>Mass effect (if macroadenoma):</strong>
            <ul>
              <li><strong>Headaches</strong> - frontal, worse in mornings</li>
              <li><strong>Visual field defects:</strong> Bitemporal hemianopia (compression of optic chiasm)</li>
              <li>Cranial nerve palsies (if cavernous sinus invasion)</li>
              <li>Pituitary apoplexy (sudden hemorrhage into adenoma - neurosurgical emergency)</li>
            </ul>
          </li>
        </ul>

        <p><strong>Diagnosis:</strong></p>
        <ul>
          <li><strong>Serum prolactin:</strong>
            <ul>
              <li>>1000 mU/L → prolactinoma likely</li>
              <li>>5000 mU/L → macroprolactinoma likely</li>
              <li>500-1000 mU/L → consider other causes (medications, stress, PCOS)</li>
            </ul>
          </li>
          <li><strong>Check macroprolactin:</strong> If borderline elevation - some assays detect inactive prolactin (macroprolactin) which is not clinically significant</li>
          <li><strong>MRI pituitary:</strong> If prolactin >1000 or any visual symptoms/headaches</li>
          <li><strong>Visual field testing (perimetry):</strong> If macroadenoma or visual symptoms</li>
          <li><strong>Other pituitary hormones:</strong> Check for hypopituitarism if large tumour (cortisol, TFTs, IGF-1)</li>
        </ul>

        <p><strong>Management of Prolactinoma:</strong></p>

        <p><strong>Medical Treatment (First-line):</strong></p>
        <ul>
          <li><strong>Dopamine agonists:</strong>
            <ul>
              <li><strong>Cabergoline</strong> - First-line (long-acting, taken 1-2x/week)
                <ul>
                  <li>Starting dose: 250-500mcg once weekly, titrate up to 0.5-3mg/week</li>
                  <li>80-90% normalise prolactin, 70-80% shrink tumour</li>
                  <li>Fewer side effects than bromocriptine</li>
                </ul>
              </li>
              <li><strong>Bromocriptine</strong> - Alternative (shorter-acting, taken daily)
                <ul>
                  <li>Starting dose: 1.25mg at night, titrate to 2.5-15mg/day</li>
                  <li>More side effects (nausea, dizziness, postural hypotension)</li>
                  <li>Preferred in pregnancy (more safety data)</li>
                </ul>
              </li>
            </ul>
          </li>
          <li><strong>Mechanism:</strong> Dopamine agonists suppress prolactin secretion and shrink tumour</li>
          <li><strong>Monitoring:</strong>
            <ul>
              <li>Serum prolactin at 4-6 weeks, then 3-6 monthly</li>
              <li>MRI pituitary at 6-12 months to assess tumour shrinkage</li>
              <li>Visual fields if macroadenoma</li>
            </ul>
          </li>
          <li><strong>Duration:</strong> Usually long-term (years). Can attempt withdrawal after 2-3 years if prolactin normalized and tumour shrunk</li>
        </ul>

        <p><strong>Surgical Treatment (Trans-sphenoidal adenomectomy):</strong></p>
        <ul>
          <li><strong>Indications:</strong>
            <ul>
              <li>Intolerance/resistance to dopamine agonists</li>
              <li>Visual field defects not improving with medication</li>
              <li>Pituitary apoplexy</li>
              <li>Patient preference (rare)</li>
            </ul>
          </li>
          <li><strong>Cure rate:</strong> 70-90% for microadenomas, 30-50% for macroadenomas</li>
          <li><strong>Complications:</strong> Hypopituitarism, diabetes insipidus, CSF leak</li>
        </ul>

        <p><strong>Radiotherapy:</strong></p>
        <ul>
          <li>Third-line - only if medication and surgery fail</li>
          <li>Slow effect (years), high risk of hypopituitarism</li>
        </ul>

        <p><strong>Fertility and Pregnancy:</strong></p>
        <ul>
          <li>Dopamine agonists restore fertility in 80-90%</li>
          <li><strong>During pregnancy:</strong>
            <ul>
              <li>Usually stop cabergoline once pregnant (switch to bromocriptine if needed)</li>
              <li>Microprolactinomas rarely enlarge in pregnancy (\&lt;5%)</li>
              <li>Macroprolactinomas may enlarge (20-30%) - monitor visual fields</li>
            </ul>
          </li>
        </ul>

        <p><strong>This patient's management:</strong></p>
        <ol>
          <li><strong>Diagnosis:</strong> 12mm prolactinoma (macroadenoma) with suprasellar extension and optic chiasm compression</li>
          <li><strong>Urgent referral to endocrinology</strong></li>
          <li><strong>Start cabergoline:</strong> 250mcg once weekly, titrate up based on prolactin levels
            <ul>
              <li>Goal: Normalize prolactin, shrink tumour, restore menstrual function, improve visual fields</li>
            </ul>
          </li>
          <li><strong>Ophthalmology review:</strong> Formal visual field testing (perimetry)</li>
          <li><strong>Monitoring:</strong>
            <ul>
              <li>Prolactin levels every 4-6 weeks</li>
              <li>MRI pituitary at 6 months (expect tumour shrinkage)</li>
              <li>Repeat visual fields in 3-6 months</li>
            </ul>
          </li>
          <li><strong>Prognosis:</strong> Excellent response expected to cabergoline - prolactin normalization, tumour shrinkage, restoration of menses and fertility</li>
        </ol>
      </div>
    </div>

    <h2>Key Learning Points</h2>
    <div class="key-points">
      <ul>
        <li><strong>Secondary amenorrhoea</strong> = absence of periods for >3 months (previously regular) or >6 months (previously irregular)</li>
        <li><strong>ALWAYS exclude pregnancy first</strong> - urine βhCG mandatory in all cases</li>
        <li><strong>Common causes:</strong> Pregnancy (most common!), PCOS (40%), hypothalamic (35% - stress, weight loss, exercise), hyperprolactinaemia (20%), POI</li>
        <li><strong>First-line investigations:</strong> βhCG, prolactin, TFTs, FSH/LH, testosterone</li>
        <li><strong>Prolactin >1000 mU/L</strong> suggests prolactinoma → MRI pituitary required</li>
        <li><strong>Prolactinoma:</strong> Pituitary adenoma secreting prolactin → amenorrhoea + galactorrhoea ± mass effect (headaches, visual field defects)</li>
        <li><strong>Macroadenoma (\&gt;10mm)</strong> may compress optic chiasm → bitemporal hemianopia</li>
        <li><strong>Treatment: Dopamine agonists (cabergoline first-line)</strong> - 80-90% normalize prolactin, 70-80% shrink tumour</li>
        <li><strong>Surgery (trans-sphenoidal)</strong> reserved for medication failure/intolerance or visual emergency</li>
        <li><strong>Dopamine agonists restore fertility</strong> - usually stop cabergoline in pregnancy (microprolactinomas safe, monitor macroprolactinomas)</li>
        <li><strong>Differential for low FSH/LH:</strong> Hypothalamic (stress, weight loss, exercise) vs pituitary (prolactinoma)</li>
        <li><strong>Differential for high FSH:</strong> Premature ovarian insufficiency (POI) - menopause &lt;40 years</li>
      </ul>
    </div>

  </div>

  <!-- JavaScript -->  <script src="../../js/firebase-config.js"></script>
  <script src="../../js/dark-mode.js"></script>
  <script src="../../js/auth.js"></script>
  <script src="../../js/user-analytics.js"></script>
  <script src="../../js/analytics-integration.js"></script>
  <script src="../../js/completion-tracker.js"></script>
  <script src="../../js/flag-tracker.js"></script>
  <script src="../../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        
    }
      
    }
    
    }
// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      
    }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      
    }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          
    }
        }, 100);
      
    }
    });
    
    }
  </script>

</body>
</html>
